BMJ Pre-Submission Checklist: Clinical Practice Readiness
BMJ desk rejects ~70% of submissions within days. Verify these 10 items covering clinical practice impact, international relevance, and what editors evaluate in the first read.
•5 min read
Associate Professor, Clinical Medicine & Public Health
Associate Professor, Clinical Medicine & Public Health
An associate professor with 14+ years in clinical medicine and epidemiology, spanning randomized controlled trials, population cohort studies, and health policy research. Has prepared manuscripts for and served as an informal pre-submission reviewer targeting NEJM, JAMA, BMJ, and The Lancet. Brings specific experience with the framing requirements for clinical trial manuscripts, CONSORT compliance, statistical reporting standards at top clinical journals, and the particular standards for global health submissions to The Lancet.
Clinical trialsEpidemiologyHealth policyCONSORT complianceClinical journal strategyNEJM submission standardsJAMA editorial criteriaBMJ manuscript requirementsLancet global health scopeSystematic reviewsPre-submission review
Journals reviewed for:
NEJM, JAMA, BMJ, The Lancet, Lancet Oncology
Research published in:
Published in NEJM, JAMA, BMJ, and The Lancet
Articles by this reviewer (213)
JAMA Pre-Submission Checklist: What to Verify Before Upload
JAMA desk rejects ~85% of submissions but decides fast (~14 days). Verify these 10 items covering clinical practice impact, statistical rigor, and the JAMA Network transfer option.
•4 min read
The Lancet Pre-Submission Checklist: Global Health Readiness
The Lancet desk rejects over 80% of submissions within 1-2 weeks. Verify these 10 items covering global health relevance, clinical significance, and what editors screen for first.
•4 min read
NEJM Pre-Submission Checklist: Is Your Paper Ready for the World's Most Cited Medical Journal?
NEJM desk rejects ~90% of submissions within 2 weeks. Before you submit, verify these 12 items covering clinical impact, trial registration, statistical rigor, and what editors screen for first.
•5 min read
Pre-Submission Review Before Resubmission: Is It Worth It?
Your paper was rejected and you are about to resubmit to another journal. Here is when review before resubmission prevents another 3-6 month rejection cycle and when you can skip it.
•6 min read
Pre-Submission Review for Non-Native English Speakers: What Language Editing Misses
Language editing fixes grammar. Pre-submission review fixes the framing, claim calibration, and editorial positioning that non-native English speakers struggle with most. Here is why you probably need both.
•6 min read
Circulation Review Time: What to Expect From Submission to Decision
Circulation review time is about 17 days to first decision, with full review often taking 4 to 8 weeks. Full 2026 timeline and AHA workflow.
•7 min read
Endoscopy Impact Factor 2026: 12.8, Q1, Rank 2/312
Endoscopy impact factor is 12.8 with a 5-year JIF of 10.3. See rank, quartile, JCI, and what this number really means for gastroenterology authors.
•6 min read
Endoscopy Review Time: What Authors Can Actually Expect
Endoscopy does not publish a polished median dashboard, but official accepted-manuscript pages make the accepted-paper path visible enough to plan around.
•8 min read
European Heart Journal Impact Factor 2026: 35.6, Q1, Rank 3/230
European Heart Journal impact factor is 35.6 with a 5-year JIF of 34.4. See rank, trend, and what that means before submission.
•6 min read
Gastroenterology Impact Factor 2026: 25.1, Q1, Rank 5/147
Gastroenterology impact factor is 25.1 with a 5-year JIF of 26.9. See rank, trend, and what that number means before submission.
•6 min read
How to Avoid Desk Rejection at Endoscopy (2026)
Avoid desk rejection at Endoscopy with stronger procedural consequence, more credible study design, and a clearer endoscopist-facing lesson.
•8 min read
How to Avoid Desk Rejection at IEEE Reviews in Biomedical Engineering (2026)
Avoid desk rejection at IEEE RBME by submitting a critical review with broad BME value, clear article type, and a strong future-directions frame.
•8 min read
How to Avoid Desk Rejection at International Journal of Oral Science (2026)
Avoid desk rejection at International Journal of Oral Science with broader oral-science fit and stronger mechanistic depth.
•8 min read
How to Avoid Desk Rejection at JCI Insight (2026)
Avoid desk rejection at JCI Insight with stronger field advance, broader physician-scientist relevance, and cleaner translational logic.
•8 min read
How to Avoid Desk Rejection at Journal of Biomedical Science (2026)
Avoid desk rejection at Journal of Biomedical Science with stronger biomedical breadth, deeper mechanism, and clearer medical consequence.
•8 min read
How to Avoid Desk Rejection at Molecular Therapy (2026)
Avoid desk rejection at Molecular Therapy with stronger platform relevance, cleaner translational support, and a clearer flagship-journal fit.
•8 min read
How to Avoid Desk Rejection at NEJM Evidence (2026)
Avoid desk rejection at NEJM Evidence by proving real clinical-evidence value, not just a decent study under a strong brand.
•8 min read
How to Avoid Desk Rejection at Pharmacology & Therapeutics (2026)
Avoid desk rejection at Pharmacology & Therapeutics by treating it as an invitation-gated review venue, not a normal cold-submission journal.
•8 min read
How to Avoid Desk Rejection at Protein & Cell (2026)
Avoid desk rejection at Protein & Cell with stronger breadth, cleaner mechanism, and a more submission-ready first read.
•8 min read
How to Avoid Desk Rejection at TEM (2026)
Avoid desk rejection at TEM with a stronger review thesis, cleaner article type, and a sharper endocrinology or metabolism angle.
•8 min read
IEEE RBME Impact Factor 2026: 12.0, Q1, Rank 6/124
IEEE RBME impact factor is 12.0 with a 5-year JIF of 13.1. See rank, trend, and what it means before submission.
•6 min read
JAMA Oncology Impact Factor 2026: 20.1, Q1, Rank 14/326
JAMA Oncology impact factor is 20.1 with a 5-year JIF of 24.7. See the rank, trend, and what that number means before submission.
•6 min read
Journal of Biomedical Science Impact Factor 2026: 12.1, Q1, Rank 9/195
Journal of Biomedical Science impact factor is 12.1 with a 5-year JIF of 12.0. See rank, trend, and what it means before submission.
•6 min read
Molecular Psychiatry Impact Factor 2026: 10.1, Q1, Rank 7/288
Molecular Psychiatry impact factor is 10.1 with a 5-year JIF of 11.8. See the rank, trend, and what that number means before submission.
•6 min read
Molecular Therapy Impact Factor 2026: 12.0, Q1, Rank 5/191
Molecular Therapy impact factor is 12.0 with a 5-year JIF of 12.4. See rank, trend, and what it means before submission.
•6 min read
Molecular Therapy Review Time: What Authors Can Actually Expect
Molecular Therapy's official public timeline points to a several-month path, even though small-sample community reports can look much faster.
•8 min read
NEJM Evidence Submission Guide: What to Prepare Before You Submit
A practical NEJM Evidence submission guide for authors deciding whether the manuscript truly belongs in a methods-conscious clinical-evidence journal from NEJM Group.
•10 min read
Nutrients Impact Factor 2026: 5.0, Q1, Rank 17/112
Nutrients impact factor is 5.0 with a 5-year JIF of 6.0. See the rank, trend, and what that number means before submission.
•6 min read
Nutrients Review Time: What Authors Can Actually Expect
Nutrients moves faster than many traditional nutrition journals, but the speed only helps if the paper is genuinely about nutrition and the compliance surface is already clean.
•8 min read
Pharmacology & Therapeutics Impact Factor 2026: 12.5, Q1, Rank 9/352
Pharmacology & Therapeutics impact factor is 12.5 with a 5-year JIF of 14.0. See rank, trend, and what it means before you pitch.
•6 min read
Protein & Cell Impact Factor 2026: 12.8, Q1, Rank 18/204
Protein & Cell impact factor is 12.8 with a 5-year JIF of 19.5. See rank, trend, and what it means before submission.
•6 min read
TEM Impact Factor 2026: 12.6, Q1, Rank 8/191
TEM impact factor is 12.6 with a 5-year JIF of 12.5. See rank, trend, and what it means before you pitch.
•6 min read
How to Avoid Desk Rejection at Gastroenterology
A practical guide to the papers Gastroenterology rejects before review, and what to fix before submitting a GI flagship manuscript.
•10 min read
How to Prepare Manuscript for Journal Submission: The 6-Dimension Checklist (2026)
Formatting checklists won't get your paper through triage. Editors screen for six things: journal fit, claim calibration, methods completeness, figure quality, citation integrity, and reporting compliance. Here is how to check each one before you submit.
•10 min read
Why Manuscripts Get Rejected: The Real Reasons by Stage and Discipline (2026)
Most manuscript rejections fall into predictable, fixable categories. This page breaks down why papers fail at desk review versus peer review, what failure patterns look like by discipline, and what the data actually shows about rejection rates by stage.
•9 min read
How to Avoid Desk Rejection at NEJM
How to avoid desk rejection at NEJM: prove broad clinical consequence, hard endpoints, and study authority strong enough for general medicine.
•13 min read
BMJ Open Acceptance Rate: What 27% Actually Means
BMJ Open now reports a 27% acceptance rate on its journal statistics page. The real filter is still methodological soundness, transparent reporting, and broad medical relevance.
•7 min read
BMJ Open APC and Open Access: The Clinical Megajournal With Published Peer Reviews
BMJ Open charges GBP 2,163 (~$2,850 USD) for gold open access. Open peer review, clinical focus, institutional deals. Full cost breakdown and comparisons.
•8 min read
Circulation APC and Open Access: Current AHA Hybrid Pricing, Coverage, and When to Pay
Circulation APC is roughly $4,000-$5,000. AHA hybrid OA, coverage options, metrics context, and when the fee is worth paying.
•8 min read
Nature Medicine Pre-Submission Checklist: Clinical Readiness Check
Before you submit to Nature Medicine, verify these 10 items covering clinical significance, translational depth, study design adequacy, and the editorial standards that stop 70-80% of submissions.
•5 min read
The Manuscript Submission Crisis: Why Getting Published Is Harder in 2026
Journal submissions surged dramatically in late 2025. Desk rejection rates are rising. Review times are stretching. Here is what is happening, why, and how to adapt your submission strategy.
•4 min read
Is JACC a Good Journal? A Practical Fit Verdict
A practical JACC fit verdict for authors deciding whether their study really belongs in the flagship cardiology journal rather than a specialty title.
•10 min read
Pre-Submission Manuscript Review: The Complete Guide for Researchers (2026)
The definitive guide to pre-submission manuscript review: what it is, what it costs across providers, when AI is enough vs when you need a human expert, and how to decide if it is worth it for your paper.
•9 min read
Best Manuscript Review Services (2026): Honest Comparison
We compared every major manuscript review service by what they actually deliver, not what they claim. Here is what each offers, what they charge, and why the differences matter more than the prices.
•7 min read
Is AJE Worth It? What You Get for $289 (Honest Assessment)
Is AJE worth $289 for pre-submission review? Here is what the service actually delivers based on their own documentation, what it misses, and when cheaper alternatives provide more actionable feedback.
•7 min read
When Pre-Submission Review Is NOT Worth It: Honest Cases
Pre-submission review is not always the right choice. Here are the specific situations where you should skip it, when a free check is sufficient, and when the investment genuinely pays for itself.
•7 min read
How to Choose a Manuscript Review Service: A Decision Framework for Researchers
There are now dozens of manuscript review services. Here is a practical decision framework that helps you choose based on what your paper actually needs, not on marketing.
•6 min read
Pre-Submission Review for First-Time Authors: What You Don't Know Can Get You Rejected
Publishing your first academic paper is harder than your advisor told you. The mistakes first-time authors make are predictable, preventable, and often invisible until a reviewer points them out.
•6 min read
Pre-Submission Review for Pharmacology Manuscripts: What Reviewers Expect in 2026
Pharmacology manuscripts need dose-response data, proper controls, in vivo validation, and clear therapeutic relevance. Here is what reviewers at top pharmacology journals expect.
•6 min read
How to Respond to Reviewer Comments: A Practical System That Works
A practical system for responding to reviewer comments without sounding defensive, skipping key points, or making the editor work harder than necessary.
•6 min read
BMJ (British Medical Journal) Formatting Requirements: The Submission Package Guide
BMJ formatting is not mainly visual style. It is a disciplined general-medical package with structured reporting, patient involvement, and clean transparency.
•11 min read
BMJ (British Medical Journal) Submission Guide: What Editors Screen Before Review
This BMJ submission guide helps authors decide whether the paper is broad enough, mature enough, and clear enough for a flagship general-medical screen.
•10 min read
Gastroenterology Submission Guide: What Editors Screen Before Review
This Gastroenterology submission guide helps authors decide whether a GI manuscript has enough clinical or translational significance for the AGA flagship.
•8 min read
IEEE Reviews in Biomedical Engineering Submission Guide: What to Prepare Before You Submit
A practical RBME submission guide for authors deciding whether their review is broad enough, critical enough, and complete enough for editorial screening.
•9 min read
International Journal of Oral Science Submission Guide: What to Prepare Before You Submit
A practical International Journal of Oral Science submission guide for authors deciding whether the paper is strong enough, broad enough, and complete enough for this selective oral-science journal.
•8 min read
JCI Insight Submission Guide: What to Prepare Before You Submit
A practical JCI Insight submission guide for authors deciding whether the manuscript is broad enough, disease-relevant enough, and complete enough for the journal's editorial screen.
•8 min read
Journal of Biomedical Science Submission Guide: What to Prepare Before You Submit
A practical Journal of Biomedical Science submission guide for authors deciding whether the paper is broad enough, molecular enough, and biomedical enough for the journal's editorial screen.
•8 min read
Molecular Therapy Submission Guide: What to Prepare Before You Submit
A practical Molecular Therapy submission guide for authors deciding whether the manuscript is strong enough, translational enough, and field-defining enough for this ASGCT flagship journal.
•9 min read
Nutrients Submission Guide: What Editors Screen Before Review
This Nutrients submission guide helps authors decide whether the manuscript is genuinely a nutrition paper and whether the package is ready for a fast editorial screen.
•8 min read
Pharmacology & Therapeutics Submission Guide: What to Know Before You Pitch
A practical Pharmacology & Therapeutics submission guide for authors deciding whether the journal is even an available target for their review idea.
•9 min read
PLOS Medicine Cover Letter: What Editors Actually Need to See
PLOS Medicine cover letters work when they explain why the study belongs in a global clinical and public-health journal, not just in a local medical context.
•10 min read
PLOS Medicine Formatting Requirements: The Submission Package Guide
PLOS Medicine formatting problems are usually package-stage problems: understanding the format-free initial submission, preparing the full submission later, and keeping abstract, cover letter, and reporting files aligned.
•10 min read
PLOS Medicine Review Time: What Authors Can Actually Expect
PLOS Medicine is a journal where the first useful timing question is whether the editors think the paper matters beyond one health system, not just how quickly reviewers reply.
•8 min read
Protein & Cell Submission Guide: What to Prepare Before You Submit
A practical Protein & Cell submission guide for authors deciding whether the manuscript is broad enough, mechanistically strong enough, and complete enough for editorial screening.
•9 min read
Science Translational Medicine Review Time: What Authors Can Actually Expect
Science Translational Medicine is one of the clearest examples of a translational journal with a sharp desk filter. The journal can reject quickly, but the files that survive often enter a longer and more revision-heavy process.
•8 min read
Trends in Endocrinology & Metabolism Submission Guide: What to Know Before You Pitch
A practical Trends in Endocrinology & Metabolism submission guide for authors deciding whether the journal is the right editorial home for their review or opinion idea.
•9 min read
How to Improve a Manuscript Before Submission: The 6-Dimension Method (2026)
Most manuscript improvement advice is too generic to act on. This guide maps improvement to the six dimensions editors actually use during triage, with named failure patterns and a one-pass fix protocol for each.
•10 min read
Is Enago Worth It for Manuscript Review? (2026)
Is Enago worth it for manuscript review? It depends on which Enago review tier you mean, what problem you are trying to solve, and whether you need broad support or a narrower submission-readiness answer.
•6 min read
How Pre-Submission Review Works: Process, Timeline, and What to Expect
Not sure what pre-submission review actually involves? Here is the step-by-step process from upload to revision, what you receive at each stage, and how long it takes.
•7 min read
PLOS Medicine Submission Process: What Happens After Your Initial Submission
A practical PLOS Medicine submission process guide covering the two-stage submission workflow, editorial screening, peer review stages, and what each decision means.
•6 min read
Pre-Submission Review for Clinical Trial Manuscripts: What Reviewers and Editors Check First
Clinical trial manuscripts face the toughest editorial scrutiny in academic publishing. Here is what editors and reviewers check first, why CONSORT 2025 changes the requirements, and how to prepare before submission.
•6 min read
How to Avoid Desk Rejection at PLOS Medicine
PLOS Medicine desk rejects roughly half of initial submissions within 2 weeks. Here is what editors actually screen for and how to avoid the most common triage failures.
•6 min read
Pre-Submission Review for Systematic Reviews and Meta-Analyses: PRISMA 2020 and Beyond
Systematic reviews and meta-analyses face unique rejection triggers that differ from original research. Here is what editors check first, what PRISMA 2020 requires, and how to prepare.
•6 min read
JAMA 'Under Review': What Each Status Means and What It Signals About Your Paper
What Under Review, Awaiting Decision, and every other JAMA status means, plus what the independent statistical reviewer is actually evaluating when your paper is in review.
•7 min read
Nature Medicine 'Under Consideration': What Each Status Means and When to Expect a Decision
If your Nature Medicine submission shows Under Consideration, here is what each status means, how long each stage typically takes, and when a follow-up is reasonable.
•5 min read
BMJ 'Under Review': What Each Status Means and When to Expect a Decision
What Awaiting PRM Assignment, Under Review, and every other BMJ status means, including what the independent statistical reviewer is evaluating when your paper is in review.
•6 min read
BMJ Open Under Review: What the Status Means and How Long It Takes
BMJ Open 'Under Review' means your paper is with peer reviewers. First decisions take 8-16 weeks. Status meanings and when to follow up.
•4 min read
Rejected from BMJ Open? The 7 Best Journals to Submit Next
After rejection from BMJ Open, consider PLOS ONE for methodologically sound work, BMC Public Health for epidemiology, JMIR for digital health, or BMC Medicine if your paper is stronger than you think.
•7 min read
Rejected from The BMJ? The 7 Best Journals to Submit Next
Paper rejected from The BMJ? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
•7 min read
Rejected from Circulation? The 7 Best Journals to Submit Next
Paper rejected from Circulation? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
•7 min read
Rejected from European Heart Journal? The 7 Best Journals to Submit Next
After rejection from European Heart Journal, consider Circulation or JACC as direct competitors, EHJ sister journals for subspecialty work, or Heart and JAHA for solid mid-tier cardiovascular research.
•10 min read
Rejected from Gastroenterology? The 7 Best Journals to Submit Next
After rejection from Gastroenterology, consider Gut for translational GI research, American Journal of Gastroenterology for clinical work, or Clinical Gastroenterology and Hepatology as the AGA companion cascade.
•10 min read
Rejected from Gut? The 7 Best Journals to Submit Next
Paper rejected from Gut? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
•7 min read
Rejected from Hepatology? The 7 Best Journals to Submit Next
After rejection from Hepatology, Journal of Hepatology is the direct European counterpart with a higher IF. Gastroenterology and Gut cover GI-liver overlap, and Hepatology Communications provides a natural AASLD cascade.
•10 min read
Rejected from JAMA? The 7 Best Journals to Submit Next
Paper rejected from JAMA? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
•11 min read
Rejected from NEJM? The 7 Best Journals to Submit Next
Paper rejected from NEJM? 7 alternative journals ranked by fit, with IF, acceptance rates, and scope comparison. Your best next steps.
•10 min read
Is Journal of Clinical Investigation a Good Journal? A Practical Fit Verdict for Authors
A practical fit verdict for authors deciding whether their disease-mechanism manuscript is realistically strong enough for Journal of Clinical Investigation.
•10 min read
Free Manuscript Review: What You Get, What You Don't, and Whether It's Enough
There are five tools that offer free manuscript review. They do very different things. This page explains what each one actually catches, where each one stops, and how to decide whether free is enough before you submit.
•7 min read
Manuscript Quality Check: The 6-Dimension Framework Editors Actually Use (2026)
Most manuscript quality checks focus on grammar and formatting. Editors triage on six different dimensions: journal fit, claim calibration, methods completeness, figure quality, citation integrity, and reporting compliance. Here is how to self-assess each one before you submit.
•9 min read
Thesify Review (2026): What It Does Well and Where It Falls Short
Thesify is a well-built academic writing tool for students and graduate researchers. It handles argument structure, rubric-based feedback, and literature search. For journal-submission readiness at selective journals, it has real gaps.
•7 min read
What Peer Reviewers Do in the First 10 Minutes: A Behavioral Guide (2026)
Peer reviewers don't read your manuscript cover to cover. They form a provisional accept-or-reject judgment in the first 10 minutes, and the rest of the review largely confirms that initial read. The sequence differs by journal tier, and understanding it changes how you should structure your manuscript.
•9 min read
What Do Peer Reviewers Look For? The Actual Criteria by Journal Tier (2026)
Peer review criteria aren't the same across journals. At Nature and Cell, reviewers are gatekeeping significance. At PLOS ONE, they're checking soundness only. Here's what your target journal's reviewers are actually evaluating.
•8 min read
BMJ Open Review Time: What Authors Can Actually Expect
BMJ Open is not mainly a speed journal. The useful submission question is whether the open-review, broad-medicine model fits your paper better than a tighter specialty venue.
•6 min read
BMJ Acceptance Rate 2026: How Selective Is the Open Peer Review Journal?
BMJ accepts about 7% of submissions. Here's what the number means, where the real filter sits, and when BMJ is a better fit than JAMA or The Lancet.
•3 min read
BMJ vs JAMA Oncology: Which Journal Should You Choose?
The BMJ is for oncology papers with broad clinical, policy, or systems consequences. JAMA Oncology is for top-tier oncology work whose real audience is still cancer medicine.
•6 min read
European Heart Journal vs Blood: Which Journal Should You Choose?
European Heart Journal is stronger for broad cardiovascular papers. Blood is stronger for hematology papers with real field-wide consequence across blood biology and disorders.
•6 min read
European Heart Journal vs BMJ Open: Which Journal Should You Choose?
European Heart Journal is the better first target for broad cardiovascular papers. BMJ Open is stronger for sound, publishable work that values methodological credibility over flagship selectivity.
•6 min read
European Heart Journal vs Journal of Clinical Oncology: Which Journal Should You Choose?
European Heart Journal is for top-tier cardiovascular papers. Journal of Clinical Oncology is for broad clinical-oncology papers with strong field-level consequence.
•6 min read
European Heart Journal vs Lancet Oncology: Which Journal Should You Choose?
European Heart Journal is for top-tier cardiovascular papers. Lancet Oncology is for practice-changing oncology work with global relevance.
•6 min read
JAMA vs Hepatology: Which Journal Should You Choose?
JAMA is for liver papers with broad clinical or policy consequence across medicine. Hepatology is for top-tier liver papers whose deepest value still belongs inside the field.
•6 min read
The Lancet vs Clinical Infectious Diseases: Which Journal Should You Choose?
The Lancet is for infectious-disease papers that become broad clinical or global-health events. CID is for strong clinician-facing ID papers that still belong primarily to infectious disease.
•6 min read
The Lancet vs Diabetes Care: Which Journal Should You Choose?
The Lancet is for rare diabetes papers that become broad clinical events. Diabetes Care is for strong clinical diabetes papers with direct management and outcomes relevance.
•6 min read
The Lancet vs Gut: Which Journal Should You Choose?
The Lancet is for GI papers that become broad medical or global-health events. Gut is for top-tier gastroenterology papers with strong translational or clinical consequence.
•6 min read
New England Journal of Medicine vs European Heart Journal: Which Journal Should You Choose?
This isn't really a prestige contest. It's a fit contest. NEJM is for cardiovascular papers that change practice across medicine. European Heart Journal is for top-tier cardiology papers that speak directly to the field.
•6 min read
Nature Medicine Submission Guide: What to Prepare Before You Submit
A practical Nature Medicine submission guide for authors deciding whether the manuscript is translationally strong enough, clinically relevant enough, and complete enough for the journal.
•12 min read
NEJM Submission Guide
A practical NEJM submission guide for authors deciding whether the manuscript has the clinical consequence, breadth, and package quality NEJM expects.
•6 min read
JAMA Impact Factor 2026: Ranking, Quartile & What It Means
JAMA impact factor is 55.7 (JCR 2024), CiteScore 30.8, SJR 5.352. Five-year JIF 64.7, Q1, rank 3/332.
•6 min read
Is BMC Medicine a Good Journal? The Open-Access General Medicine Option
BMC Medicine (IF 8.3) is the strongest open-access general medicine journal below the Big 4. Here's when it's the right target and when to aim higher or narrower.
•9 min read
NEJM Acceptance Rate 2026: What the Numbers Mean
NEJM accepts 5-6% of manuscripts and desk-rejects over 90%. The numbers matter, but the more useful question is whether your paper is broad and practice-changing enough to clear the desk.
•8 min read
The Lancet Acceptance Rate 2026: Stats and What They Mean
The Lancet accepts roughly 4-5% of submitted manuscripts, with over 80% desk-rejected in 1-2 weeks. Here's what the stage-by-stage data looks like and what determines whether your paper clears each stage.
•8 min read
Journal Cover Letter Template: 5 Filled-In Examples for Any Journal (2026)
Most cover letters fail because researchers write summaries instead of pitches. Here are 5 complete, filled-in templates for different journal tiers and fields: copy, adapt, submit.
•10 min read
The Lancet Submission Process: Steps & Timeline
A practical The Lancet submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
•7 min read
JAMA Submission Process: Steps & Timeline
A workflow-focused JAMA submission process guide covering what happens after upload, how triage works, and where papers get redirected or delayed.
•10 min read
How to Avoid Desk Rejection: The Complete Guide for Any Journal (2026)
30 to 70% of manuscripts are desk rejected without ever reaching peer review. Here is how to avoid it at any journal, from PLOS ONE to Nature.
•8 min read
European Heart Journal Submission Guide: Requirements & Editor Tips
A practical European Heart Journal submission guide covering package readiness, broad-cardiology fit, and what to tighten before upload.
•15 min read
Is BMJ Open a Good Journal? An Honest Assessment
BMJ Open fits sound clinical work, protocols, and negative results. When a selective specialty journal is the better call.
•12 min read
Is PLOS ONE a Good Journal? Predatory or Legitimate?
A practical PLOS ONE verdict for authors deciding whether the journal is legitimate, what its editorial model actually means, and when it is the right fit.
•12 min read
BMJ Impact Factor 2026: 42.7, Q1, Rank 5/332
BMJ IF 42.7 (JCR 2024), Q1, rank 5/332. Five-year JIF 76.1 is pandemic-inflated; 42.7 is the real baseline. Under 7% acceptance. What BMJ actually publishes.
•9 min read
BMC Medicine Impact Factor 2026: 8.3 - One of Open Access Medicine's Best
BMC Medicine IF dropped from 12.5 to 8.3 after COVID normalization. Five-year JIF 9.4 is the real baseline. Q1, $3,054 APC, PubMed-indexed OA.
•5 min read
PLOS Medicine Impact Factor 2026: 9.9 - A Top-Tier Open Access Medical Journal
PLOS Medicine impact factor is 9.9 (JCR 2024). Q1, rank 13/332 in Medicine. APC $5,300 with waivers. See the trend and submission guidance.
•5 min read
Circulation Impact Factor 2026: 38.6, Q1, Rank 1/98
Circulation impact factor is 38.6. Five-year JIF is 35.9. Quartile: Q1. Category rank: 1/98.
•5 min read
Diabetes Care Impact Factor 2026: Ranking, Quartile & What It Means
Diabetes Care impact factor is 16.6. Five-year JIF 14.5, Q1, rank 6/191. See comparisons and what it means for authors.
•6 min read
Trends in Molecular Medicine Impact Factor 2026: 13.8, Q1, Rank 4/195
Trends in Molecular Medicine impact factor is 13.8 with a 5-year JIF of 14.4. Q1, rank 4/195. Comparisons and what it means.
•7 min read
eLife Impact Factor 2026: Why It's No Longer Listed
eLife impact factor is approximately 6.4 (estimated). Q1 in Biology. APC $2,500, no desk rejections for reviewed papers. The journal redefining peer review.
•5 min read
Clinical Infectious Diseases Impact Factor 2026: Ranking, Quartile & What It Means
Clinical Infectious Diseases impact factor is 7.3. Five-year JIF 7.2, Q1, rank 8/137. See comparisons and submission guidance.
•6 min read
Lancet Impact Factor 2026: 88.5, Rank 1/332, and What It Means
The Lancet's impact factor is 88.5 in the internal JCR 2024 reference table, but the useful submission question is fit. The number signals top-tier reach, not automatic fit for every strong clinical paper.
•8 min read
Circulation vs European Heart Journal: Which Should You Submit To?
Compare Circulation vs European Heart Journal: JIF 9.9 vs 7.0 (2024 JCR), scope differences, acceptance rates, and which journal fits your cardiovascular.
•7 min read
NEJM Submission Process: Steps & Timeline
A practical NEJM submission process guide covering what happens after upload, what editors screen for first, and what to fix before you submit.
•7 min read
Annals of Oncology Formatting Requirements: Complete Author Guide
Annals of Oncology limits Original Articles to 3,000 words with a 250-word structured abstract and up to 6 figures/tables combined. References use Vancouver numbered style with square brackets, and CONSORT compliance is required for clinical trials.
•9 min read
Clinical Cancer Research Formatting Requirements: Complete Author Guide
Clinical Cancer Research limits Articles to 5,000 words with a 250-word structured abstract and up to 7 figures. A mandatory 150-word Translational Relevance statement is unique to this journal, and references use AACR numbered style with parenthetical citations.
•7 min read
European Heart Journal Review Time: What Authors Can Actually Expect
European Heart Journal often tells authors relatively quickly whether a paper belongs in flagship cardiology, but the real submission question is cardiovascular consequence across practice, not just speed.
•6 min read
Gastroenterology Formatting Requirements: Complete Author Guide
Gastroenterology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•9 min read
JAMA Formatting Requirements: Complete Author Guide
JAMA formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•9 min read
JAMA Oncology Formatting Requirements: Complete Author Guide
JAMA Oncology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•9 min read
Lancet Oncology Formatting Requirements: Complete Author Guide
Lancet Oncology formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•9 min read
Nature Medicine Formatting Requirements: Complete Author Guide
Nature Medicine formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•9 min read
NEJM Formatting Requirements: Complete Author Guide
NEJM formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•10 min read
Annals of Oncology vs Journal of Clinical Oncology: Which Journal Should You Choose?
Annals of Oncology is stronger for high-end clinical and translational oncology with a European feel. JCO is stronger for broad clinical oncology papers with practice-changing intent.
•6 min read
Annals of Oncology vs Lancet Oncology: Which Journal Should You Choose?
Annals of Oncology is stronger for top-tier clinical and translational oncology with a European perspective. Lancet Oncology is stronger for papers with clearer global practice-changing force.
•6 min read
BMJ vs Annals of Oncology: Which Journal Should You Choose?
The BMJ is for oncology papers with broad clinical, policy, or systems consequences. Annals of Oncology is for top-tier oncology work whose real audience is still cancer medicine.
•6 min read
BMJ vs Blood: Which Journal Should You Choose?
The BMJ is for hematology papers with broad clinical, policy, or systems consequences. Blood is for flagship hematology work whose real audience is still the field.
•6 min read
BMJ vs BMJ Open: Which Journal Should You Choose?
The BMJ is for broad clinical or policy papers with strong general-medical consequences. BMJ Open is for methodologically sound medical research that wins on transparency, not prestige filtering.
•7 min read
BMJ vs Clinical Cancer Research: Best Fit for Your Paper
BMJ is for oncology papers with broad clinical or policy consequences. Clinical Cancer Research is for translational oncology work whose main audience is still cancer medicine.
•6 min read
BMJ vs Clinical Infectious Diseases: Which Journal Should You Choose?
The BMJ is for infectious-disease papers with broad clinical, policy, or systems consequences. Clinical Infectious Diseases is for clinician-facing ID papers.
•6 min read
BMJ vs Diabetes Care: Which Journal Should You Choose?
The BMJ is for diabetes papers with broad clinical, policy, or systems consequences. Diabetes Care is for diabetes research whose real audience is still diabetes practice.
•6 min read
BMJ vs European Heart Journal: Which Journal Should You Choose?
BMJ is for cardiovascular papers with broad clinical, policy, or systems consequences. European Heart Journal is for flagship cardiology work whose real audience is the cardiovascular field.
•6 min read
BMJ vs Gastroenterology: Which Journal Should You Choose?
The BMJ is for GI papers with broad clinical, policy, or systems consequences. Gastroenterology is for flagship digestive-disease work whose real audience is still GI.
•6 min read
BMJ vs Gut: Which Journal Should You Choose?
The BMJ is for GI papers with broad clinical, policy, or systems consequences. Gut is for top-tier gastroenterology papers whose real audience is still digestive disease.
•6 min read
BMJ vs Hepatology: Which Journal Should You Choose?
The BMJ is for liver papers with broad clinical, policy, or systems consequences. Hepatology is for flagship liver-disease work whose real audience is still hepatology.
•6 min read
BMJ vs Journal of Clinical Oncology: Which Journal Should You Choose?
The BMJ is for cancer papers with broad clinical, policy, or systems consequences. Journal of Clinical Oncology is for top-tier oncology work whose real audience is clinical oncology.
•6 min read
BMJ vs Lancet Oncology: Which Journal Should You Choose?
The BMJ is for oncology papers with broad clinical, policy, or systems consequences. Lancet Oncology is for practice-changing oncology work with global relevance.
•6 min read
European Heart Journal vs Annals of Oncology: Which Journal Should You Choose?
European Heart Journal is for top-tier cardiovascular papers. Annals of Oncology is for top-tier oncology work with broad clinical or translational consequence.
•6 min read
European Heart Journal vs Clinical Cancer Research: Which Journal Should You Choose?
European Heart Journal is stronger for broad cardiology papers. Clinical Cancer Research is stronger for translational oncology papers with real patient-facing consequence.
•6 min read
European Heart Journal vs Clinical Infectious Diseases: Which Journal Should You Choose?
European Heart Journal is the better first target for cardiovascular papers with broad cardiology consequence. Clinical Infectious Diseases is stronger for clinically actionable ID papers.
•6 min read
European Heart Journal vs Diabetes Care: Which Journal Should You Choose?
European Heart Journal is the better first target for broad cardiovascular papers. Diabetes Care is stronger for diabetes-practice papers with clear clinical consequence.
•6 min read
European Heart Journal vs Gastroenterology: Which Journal Should You Choose?
European Heart Journal is the better first target for broad cardiovascular papers. Gastroenterology is stronger for flagship GI work that still lives inside digestive disease.
•6 min read
European Heart Journal vs Gut: Which Journal Should You Choose?
European Heart Journal is the better first target for cardiovascular papers with broad cardiology consequence. Gut is stronger for GI and hepatology work with translational depth.
•7 min read
European Heart Journal vs Hepatology: Which Journal Should You Choose?
European Heart Journal is the better first target for broad cardiovascular papers. Hepatology is stronger for liver-disease work with real mechanistic, translational, or clinical hepatology consequence.
•6 min read
European Heart Journal vs JAMA Oncology: Which Journal Should You Choose?
European Heart Journal is for top-tier cardiovascular papers. JAMA Oncology is for broad oncology papers with strong clinical consequences.
•6 min read
JAMA vs Blood: Which Journal Should You Choose?
JAMA is for hematology papers with broad clinical or policy relevance across medicine. Blood is for flagship hematology work whose real audience is the field itself.
•6 min read
JAMA vs BMJ Open: Which Journal Should You Choose?
JAMA is for broad clinical papers with strong general-medical consequences. BMJ Open is for medically relevant, transparently reported studies that win on soundness rather than prestige filtering.
•7 min read
JAMA vs Clinical Cancer Research: Which Journal Should You Choose?
JAMA is for oncology papers with broad clinical or policy consequences across medicine. Clinical Cancer Research is for translational oncology work whose real audience is still cancer medicine.
•6 min read
JAMA vs Clinical Infectious Diseases: Which Journal Should You Choose?
JAMA is for infectious-disease papers with broad clinical or policy consequences across medicine. CID is for strong clinician-facing ID papers whose real audience is still infectious disease.
•6 min read
JAMA vs Diabetes Care: Which Journal Should You Choose?
JAMA is for diabetes papers with broad clinical or public-health consequence across medicine. Diabetes Care is for papers that are strongest inside diabetes management.
•6 min read
JAMA vs European Heart Journal: Which Journal Should You Choose?
JAMA is for cardiovascular papers with broad clinical or public-health consequence. European Heart Journal is for top-tier cardiology papers whose real audience is the field itself.
•6 min read
JAMA vs Gastroenterology: Which Journal Should You Choose?
JAMA is for GI papers with broad clinical or policy consequence across medicine. Gastroenterology is for flagship digestive-disease papers that still belong inside the field.
•6 min read
JAMA vs Gut: Which Journal Should You Choose?
JAMA is for GI papers with broad clinical or policy consequence across medicine. Gut is for top-tier gastroenterology papers with strong translational or clinical consequence.
•6 min read
The Lancet vs BMJ Open: Which Journal Should You Choose?
The Lancet is for papers that become broad medical or global-health events. BMJ Open is for methodologically sound medical research that wins on transparency, not prestige filtering.
•7 min read
The Lancet vs European Heart Journal: Which Journal Should You Choose?
The Lancet is for cardiology papers that become broad medical or global-health events. European Heart Journal is for top-tier cardiovascular papers whose natural readership is the cardiology field.
•6 min read
The Lancet vs Gastroenterology: Best Fit for Your Paper
The Lancet is for digestive-disease papers that break into broad medicine. Gastroenterology is for elite GI papers whose real value still depends on specialist readership.
•6 min read
The Lancet vs Hepatology: Which Journal Should You Choose?
The Lancet is for liver papers that become broad clinical or global-health events. Hepatology is for top-tier liver papers whose deepest value still belongs inside hepatology.
•6 min read
New England Journal of Medicine vs BMJ: Which Journal Should You Choose?
NEJM and BMJ are both elite general medical journals, but they aren't interchangeable. NEJM wants definitive practice-changing evidence. BMJ is more receptive to policy, systems, and population-health relevance.
•6 min read
New England Journal of Medicine vs BMJ Open: Which Journal Should You Choose?
These journals aren't close substitutes. NEJM is for rare practice-changing medicine. BMJ Open is for sound clinical and public-health research reviewed under a more inclusive open-access model.
•6 min read
New England Journal of Medicine vs Clinical Infectious Diseases: Which Journal Should You Choose?
NEJM is for infectious-disease papers that change broad clinical medicine. Clinical Infectious Diseases is for strong, clinician-facing ID work that changes diagnosis, treatment, prevention, or stewardship.
•6 min read
New England Journal of Medicine vs Diabetes Care: Which Journal Should You Choose?
NEJM is for rare diabetes papers that become broad clinical events. Diabetes Care is the stronger first target for many high-quality clinical diabetes papers with direct practice relevance.
•6 min read
New England Journal of Medicine vs Gastroenterology: Which Journal Should You Choose?
NEJM is the play for GI papers that become broad medical events. Gastroenterology is the better first target for many top digestive-disease papers, especially when mechanistic depth and GI-specific context matter.
•6 min read
New England Journal of Medicine vs Gut: Which Journal Should You Choose?
NEJM is for gastroenterology papers that change medicine broadly. Gut is for top-tier GI work with strong translational or clinical consequence, especially in microbiome, IBD, liver, and GI oncology.
•6 min read
New England Journal of Medicine vs Hepatology: Which Journal Should You Choose?
NEJM is for liver papers that change broad clinical medicine. Hepatology is the stronger first target for many serious liver studies that are field-defining but still liver-specific.
•6 min read
Manuscript Review After Rejection: How to Strengthen Before Resubmitting
Your paper was rejected. Before resubmitting unchanged to the next journal, here is how to identify the real rejection cause, fix it, and avoid losing another 3 to 6 months in a preventable rejection cycle.
•6 min read
PLOS Medicine Submission Guide: What to Prepare Before You Submit
A practical PLOS Medicine submission guide covering the initial submission process, global health framing, reporting requirements, and what must be true before your paper enters review.
•6 min read
JAMA Submission Guide
A package-readiness guide to JAMA covering manuscript shape, Key Points, structured abstract, and general-medicine fit before upload.
•10 min read
NEJM Evidence Impact Factor in 2026: Does It Have a JIF Yet?
If you're searching NEJM Evidence impact factor, the key point is JIF status and how committees in your field view this title.
•7 min read
How to Write a NEJM Cover Letter (With Template)
NEJM desk-rejects more than 80% of submissions, often within 7 days. The cover letter is your first and sometimes only chance to make the case for why your paper belongs there.
•7 min read
How to Write a JAMA Cover Letter (With Template)
JAMA receives 6,000+ manuscripts per year and publishes fewer than 5%. The cover letter is your argument for why your research belongs in the most-read general medical journal in the US.
•6 min read
JAMA Acceptance Rate 2026: Stats and What They Mean
JAMA's overall acceptance rate is around 5%, with over 80% desk-rejected before peer review. Here's what the numbers mean and what actually determines whether your paper clears each stage.
•8 min read
What I Learned Reading 50 Cover Letters in a Week
After reading 50 cover letters for journal submissions in a single week, the patterns were painfully obvious. Here's what stood out.
•6 min read
JCI Acceptance Rate 2026: How Selective Is the Gold Standard?
JCI accepts roughly 10% of submissions. Desk rejection accounts for 60-70%. What the selectivity means for translational and clinical papers.
•7 min read
The Lancet Formatting Requirements: Complete Author Guide
The Lancet formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•9 min read
BMJ Open Impact Factor 2026: 2.3 - What That Number Actually Means for Your Paper
BMJ Open impact factor is 2.3 (JCR 2024). CiteScore 4.5, SJR 1.016. Q2 in JCR, Q1 in Scopus. See what the metrics mean for submissions.
•8 min read
Desk Rejection Rates by Journal: What the Data Shows (2026)
Desk rejection rates range from 15% at PLOS ONE to 90% at NEJM. Here is the data for 30+ major journals, what the numbers mean for your submission, and how to reduce your desk rejection risk.
•8 min read
The Real Cost of Desk Rejection: Time, Money, and Career Impact
Desk rejection costs more than a setback. The real price includes 3 to 6 months lost, APC exposure averaging $1,626, and compounding career impact for early-career researchers.
•7 min read
Is JAMA Cardiology a Good Journal? The JAMA Network's Cardiovascular Title
JAMA Cardiology (IF 14.1) is the JAMA Network's cardiovascular journal. Here's when it's the right target, how the JAMA transfer pipeline works, and how it compares to JACC, Circulation, and EHJ.
•7 min read
Manuscript Readiness Scores: What They Are and Why They Matter Before Submission
Manuscript readiness scoring evaluates whether your paper is ready for a specific journal before you submit. Here is how it works, what the dimensions mean, and how to use the results.
•4 min read
Science Translational Medicine Impact Factor 2026: JIF Snapshot & What It Means
Science Translational Medicine impact factor is 14.6 (JCR 2024). Q1, rank 3/195 in Medicine Research. h-index 357.
•6 min read
Nature Medicine Acceptance Rate 2026: How Selective Is It?
Nature Medicine accepts about 7% of submissions. IF 50.0, bridging bench and bedside. Here's what the acceptance rate means and who gets published.
•7 min read
Blood Acceptance Rate 2026: How Selective Is the ASH Flagship?
Blood accepts roughly 15-20% of submissions. What the ASH flagship selects for and how the selectivity breaks down by paper type.
•4 min read
Circulation Acceptance Rate 2026: How Selective Is the AHA Flagship?
Circulation accepts about 7% of original research submissions. What that selectivity means, where papers get filtered, and when transfer is smarter.
•4 min read
BMJ Formatting Requirements: Complete Author Guide
BMJ formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•10 min read
BMJ Open Formatting Requirements: Complete Author Guide
BMJ Open formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•12 min read
Clinical Infectious Diseases Acceptance Rate: What Authors Can Use
Clinical Infectious Diseases does not publish a strong official acceptance rate. The better submission question is whether the paper actually changes infectious-disease diagnosis, treatment, prevention, or management.
•3 min read
Diabetes Care Acceptance Rate: What Authors Can Use
Diabetes Care does not publish a strong official acceptance rate. The better submission question is whether the study could change clinical diabetes management or ADA guideline recommendations.
•3 min read
eLife Formatting Requirements: Complete Author Guide
eLife formatting guide. Word limits, figure specs, reference format, LaTeX vs Word, and journal-specific formatting quirks you need to know.
•9 min read
European Heart Journal Acceptance Rate: What Authors Can Use
European Heart Journal does not publish a strong official acceptance rate. The better submission question is whether the study is large-scale, clinically consequential, and positioned to influence ESC guidelines.
•4 min read
Gastroenterology Acceptance Rate: What Authors Can Use
Gastroenterology does not publish a strong official acceptance rate. The better submission question is whether the study advances GI or liver science with clinical or mechanistic significance at the AGA flagship level.
•3 min read
Gastroenterology Review Time: What Authors Can Actually Expect
Gastroenterology can move quickly at the desk, but the real question is not just speed. It is whether the paper is broad and complete enough to survive flagship-GI review.
•6 min read
Gut Acceptance Rate: What Authors Can Use
Gut reports some editorial metrics but does not publish a fully stable official acceptance rate. The better submission question is whether the study delivers GI research with population-level or practice-changing significance.
•3 min read
Gut Review Time: What Authors Can Actually Expect
Gut is often faster than many journals at its level, but the useful question is still fit. A quick desk answer does not change the flagship-GI bar.
•3 min read
Hepatology Acceptance Rate: What Authors Can Use
Hepatology does not publish a strong official acceptance rate. The better submission question is whether the study advances liver science with the clinical or mechanistic significance the AASLD flagship demands.
•3 min read
Hepatology Review Time: What Authors Can Actually Expect
Hepatology usually tells you fairly quickly whether the paper is in range, but the real submission question is whether the manuscript has enough liver-specific weight to justify the full review cycle.
•6 min read
NEJM Impact Factor 2026: 78.5, Rank, and What It Means
NEJM's impact factor is high, but the real submission decision is fit. The number tells you the journal's tier, not whether a strong specialty paper will survive triage.
•9 min read
Famous Scientific Papers Rejected Before Publication: 5 That Changed Science
The Krebs cycle paper got rejected because the journal had too many letters in the queue. The Higgs boson paper was never reviewed. Here's what happened after: and what it means for yours.
•7 min read
Pre-Submission Review for Postdocs: Why It Matters for Independent Career Papers
Postdoc publications define your independent career trajectory. Here is when pre-submission review has the highest ROI for career-critical papers.
•10 min read
Need expert review of your manuscript?
Our reviewers include researchers like this one who have published in and reviewed for top journals. Get a structured pre-submission review before you submit.